Literature DB >> 24939423

Microbiological isolates and antibiotic sensitivities in culture-proven endophthalmitis: a 15-year review.

Thomas P Moloney1, Joseph Park1.   

Abstract

BACKGROUND: To describe the microbiological spectrum and antibiotic sensitivities of organisms causing culture-proven endophthalmitis in Queensland, Australia, and to compare results with similar studies from other parts of Australia and other countries.
METHODS: A retrospective, multicentre, non-comparative, consecutive case series. Public hospital microbiology records from culture-positive endophthalmitis cases were reviewed over 15 years from June 1998 to June 2013. Outcome measures were type of endophthalmitis, vitreous isolates cultured and antibiotic sensitivities.
RESULTS: 205 cases of culture-proven endophthalmitis were identified with a total of 229 isolates cultured. The most common organisms isolated were Staphylococcus epidermidis in 23.1%, Coagulase-negative Staphylococcus in 12.7%, Streptococcus viridans group in 10.0%, Candida species in 6.1%, fungal mold species in 5.7%. For gram-positive organisms, sensitivities were vancomycin 100%, cephazolin 79% and penicillin 47%. For gram-negative organisms, sensitivities were ceftazidime 100%, amikacin 100%, ciprofloxacin 100% and gentamicin 95.5%. For fungal isolates, sensitivities were voriconazole 93%, ketoconazole 89%, caspofungin 70% and amphotericin B 58%.
CONCLUSIONS: The microbiological spectrum and antibiotic sensitivities of endophthalmitis cases in Queensland, Australia, is similar to the spectrum of organisms causing endophthalmitis in other parts of Australia, North America and Europe. Empirical intravitreal vancomycin, ceftazidime and voriconazole are the most appropriate empirical antibiotics for suspected infective endophthalmitis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Infection

Mesh:

Substances:

Year:  2014        PMID: 24939423     DOI: 10.1136/bjophthalmol-2014-305030

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Pathogens and antibiotic sensitivities in endophthalmitis.

Authors:  Geraldine R Slean; Neal H Shorstein; Liyan Liu; John F Paschal; Kevin L Winthrop; Lisa J Herrinton
Journal:  Clin Exp Ophthalmol       Date:  2017-01-31       Impact factor: 4.207

2.  The Susceptibility of Bacterial Endophthalmitis Isolates to Vancomycin, Ceftazidime, and Amikacin: a 23 Year-Review.

Authors:  Shilpa Kodati; Andrew W Eller; Regis P Kowalski
Journal:  Ophthalmol Retina       Date:  2017 May-Jun

3.  Inhibition of Bacteroidetes and Firmicutes by select phytochemicals.

Authors:  Jourdan E Lakes; Christopher I Richards; Michael D Flythe
Journal:  Anaerobe       Date:  2019-12-24       Impact factor: 3.331

Review 4.  Bacterial and Fungal Endophthalmitis.

Authors:  Marlene L Durand
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

5.  Trends in treatment strategies for suspected bacterial endophthalmitis.

Authors:  Greg D Fliney; Paula E Pecen; Jennifer N Cathcart; Alan G Palestine
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-07       Impact factor: 3.117

6.  Molecular and Phenotypic Characterization of Staphylococcus epidermidis Isolates from Healthy Conjunctiva and a Comparative Analysis with Isolates from Ocular Infection.

Authors:  Luis A Flores-Páez; Juan C Zenteno; María D Alcántar-Curiel; Carlos F Vargas-Mendoza; Sandra Rodríguez-Martínez; Mario E Cancino-Diaz; Janet Jan-Roblero; Juan C Cancino-Diaz
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

Review 7.  Endophthalmitis: state of the art.

Authors:  Kamyar Vaziri; Stephen G Schwartz; Krishna Kishor; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-01-08

8.  Causative Microorganisms of Infectious Endophthalmitis: A 5-Year Retrospective Study.

Authors:  Fang Duan; Kaili Wu; Jingyu Liao; Yongxin Zheng; Zhaohui Yuan; Junlian Tan; Xiaofeng Lin
Journal:  J Ophthalmol       Date:  2016-06-19       Impact factor: 1.909

Review 9.  Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review.

Authors:  Rohan Merani; Alex P Hunyor
Journal:  Int J Retina Vitreous       Date:  2015-07-21

Review 10.  Antibiotic prophylaxis in cataract surgery - An evidence-based approach.

Authors:  Aravind Haripriya
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.